JOP20180017A1 - مثبط كيناز منظم لإشارة تلاشي خلايا - Google Patents

مثبط كيناز منظم لإشارة تلاشي خلايا

Info

Publication number
JOP20180017A1
JOP20180017A1 JOP/2018/0017A JOP20180017A JOP20180017A1 JO P20180017 A1 JOP20180017 A1 JO P20180017A1 JO P20180017 A JOP20180017 A JO P20180017A JO P20180017 A1 JOP20180017 A1 JO P20180017A1
Authority
JO
Jordan
Prior art keywords
kinase inhibitor
apoptosis signal
regulating kinase
compound
formula
Prior art date
Application number
JOP/2018/0017A
Other languages
Arabic (ar)
English (en)
Inventor
Kassibla Elodie Dempah
Julie Farand
Gregory Notte
Jennifer Lynne Alleva
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of JOP20180017A1 publication Critical patent/JOP20180017A1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JOP/2018/0017A 2017-03-14 2017-03-14 مثبط كيناز منظم لإشارة تلاشي خلايا JOP20180017A1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762471300P 2017-03-14 2017-03-14

Publications (1)

Publication Number Publication Date
JOP20180017A1 true JOP20180017A1 (ar) 2019-01-30

Family

ID=61750538

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2018/0017A JOP20180017A1 (ar) 2017-03-14 2017-03-14 مثبط كيناز منظم لإشارة تلاشي خلايا

Country Status (6)

Country Link
AR (1) AR111178A1 (es)
BR (1) BR102018004862A2 (es)
JO (1) JOP20180017A1 (es)
TW (1) TW201840551A (es)
UY (1) UY37631A (es)
WO (1) WO2018169742A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI491606B (zh) 2009-07-13 2015-07-11 Gilead Sciences Inc 調節細胞凋亡信號之激酶的抑制劑
KR102629267B1 (ko) 2017-05-12 2024-01-25 이난타 파마슈티칼스, 인코포레이티드 아폽토시스 신호 조절 키나아제 １ 억제제 및 이의 사용 방법
US10597382B2 (en) 2017-08-28 2020-03-24 Enanta Pharmaceuticals, Inc. Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
EP3787621A4 (en) 2018-05-02 2022-01-12 Enanta Pharmaceuticals, Inc. APOPTOSIS SIGNAL REGULATING KINASE 1 INHIBITORS CONTAINING TETRAZOLES AND METHODS OF USE THEREOF
US10683289B2 (en) 2018-05-02 2020-06-16 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
CN110818683B (zh) * 2018-08-10 2023-04-14 中国科学院上海药物研究所 2-吡啶取代脲结构小分子化合物及其合成和应用
WO2020041417A1 (en) 2018-08-22 2020-02-27 Enanta Pharmaceuticals, Inc. Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US11345699B2 (en) 2018-11-19 2022-05-31 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US11466033B2 (en) 2019-03-25 2022-10-11 Enanta Pharmaceuticals, Inc. Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
WO2023125904A1 (zh) * 2021-12-30 2023-07-06 苏州晶云药物科技股份有限公司 氮杂环丁基烟酸类化合物的晶型及其制备方法
CN117503932A (zh) * 2022-07-30 2024-02-06 中国医学科学院阜外医院 Jun抑制剂在制备用于治疗射血分数保留的心衰的药物中的用途
CN117054652B (zh) * 2023-08-04 2024-05-17 南京医科大学 一种用于辅助检测心肌肥厚的生物标志物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI491606B (zh) 2009-07-13 2015-07-11 Gilead Sciences Inc 調節細胞凋亡信號之激酶的抑制劑
EP2545964A1 (en) 2011-07-13 2013-01-16 Phenex Pharmaceuticals AG Novel FXR (NR1H4) binding and activity modulating compounds
UY34573A (es) 2012-01-27 2013-06-28 Gilead Sciences Inc Inhibidor de la quinasa que regula la señal de la apoptosis
US20150342943A1 (en) 2014-06-03 2015-12-03 Gilead Sciences, Inc. Methods of treating liver disease
TW201618781A (zh) 2014-08-13 2016-06-01 吉李德科學股份有限公司 治療肺高血壓之方法
MA41252A (fr) * 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1

Also Published As

Publication number Publication date
AR111178A1 (es) 2019-06-12
BR102018004862A2 (pt) 2019-01-02
WO2018169742A1 (en) 2018-09-20
UY37631A (es) 2018-09-28
TW201840551A (zh) 2018-11-16

Similar Documents

Publication Publication Date Title
JOP20180017A1 (ar) مثبط كيناز منظم لإشارة تلاشي خلايا
PH12021550045A1 (en) 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
MX2022014414A (es) Compuestos de pirimidinodiona contra estados cardiacos.
PH12020551090A1 (en) Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
MX2017008417A (es) Procedimientos para preparar inhibidores de cinasa 1 reguladora de señal de apoptosis (ask1).
AR105238A1 (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso
RS54492B1 (en) KINASE INHIBITOR REGULATING THE SIGNAL PATH OF APOPTOSIS
NZ758345A (en) Ask1 inhibitor compounds and uses thereof
MA38078B1 (fr) Dérivé de pyridine
WO2014099633A3 (en) Inhibitors of the renal outer medullary potassium channel
RS54030B1 (en) PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT
MX2021006544A (es) Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
EA200802329A1 (ru) Производные триазола ii
EA202193015A1 (ru) Ингибиторы cdk
WO2009016460A8 (en) Pyrazole compounds and their use as raf inhibitors
EA201290957A1 (ru) Пиразол-4-илгетероциклилкарбоксамидные соединения и способы их применения
WO2014126944A3 (en) Inhibitors of the renal outer medullary potassium channel
SA520412335B1 (ar) مشتقات أوكسي فلورو ببريدين كمثبط كيناز
ECSP12012048A (es) Antagonistas del receptor mineralcorticoide no esteroidal
MX2019013626A (es) Modo de accion dual novedoso de activadores de guanilato ciclasa solubles e inhibidores de fosfodiesterasa y usos de los mismos.
ZA202307945B (en) Pyridopyrimidinone derivative, preparation method therefor, and use thereof
CR20140462A (es) Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil} amino) -1-hidroxietil]-8-hidroquinolin-2(1h)-ona
PH12021550449A1 (en) 2,6-diamino pyridine compounds.
RU2017121002A (ru) Ингибиторы CD38 и способы лечения
MX2023000222A (es) Compuesto heterociclico y uso del mismo.